| The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding protein. | leukemia, |
| Overexpression of Evi-1 oncoprotein represses TGF-beta signaling in colorectal cancer. | colorectal, |
| Phosphorylation of the leukemic oncoprotein EVI1 on serine 196 modulates DNA binding, transcriptional repression and transforming ability. | leukemia, |
| Evi1-high leukemic cells themselves possess the superior potential to Evi1-low cells in oncogenic self-renewal. | leukemia, |
| Results establish the oncogenic contributions of EVI1 in ER- and HER2-negative subsets of breast cancer. | breast, |
| Our data indicated that EVI1 played an oncogenic role in nasopharyngeal carcinoma growth and metastasis | nasopharyngeal,laryngeal, |
| Induction of two alternatively spliced evi-1 proto-oncogene transcripts by cAMP in kidney cells. | kidney, |
| Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression. | None |
| results suggest that oligomerization may contribute to the oncogenic potential of Evi-1-containing proteins | None |
| Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5 -ends. | None |
| The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions. | None |
| Expression and prognostic significance of different mRNA 5 -end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration. | None |
| A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a. | None |
| EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation. | None |
| Physical and functional interaction of the proto-oncogene EVI1 and tumor suppressor gene HIC1 deregulates Bcl-xL mediated block in apoptosis. | None |
| The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid. | None |
| oncogenic potential for EVI1 in modulating genomic stability | None |
| Mutations in MECOM, Encoding Oncoprotein EVI1, Cause Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia. | None |
| EVI1 contributes to PCa progression by regulating different oncogenic functions. EVI1 regulates the PCa stem cell compartment responsible for disease initiation and also development of CRPC. | None |
| The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. | None |